Alsiö, Å., Rembeck, K., Askarieh, G., Christensen, P. B., Färkkilä, M., Langeland, N., . . . Lagging, M. (2012). Impact of Obesity on the Bioavailability of Peginterferon-α2a and Ribavirin and Treatment Outcome for Chronic Hepatitis C Genotype 2 or 3. Public Library of Science.
Παραπομπή Chicago StyleAlsiö, Åsa, et al. Impact of Obesity On the Bioavailability of Peginterferon-α2a and Ribavirin and Treatment Outcome for Chronic Hepatitis C Genotype 2 or 3. Public Library of Science, 2012.
Παραπομπή MLAAlsiö, Åsa, et al. Impact of Obesity On the Bioavailability of Peginterferon-α2a and Ribavirin and Treatment Outcome for Chronic Hepatitis C Genotype 2 or 3. Public Library of Science, 2012.
Πρόσοχή: Οι παραπομπές μπορεί να μην είναι 100% ακριβείς.